v3.25.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive Income (loss)
Non- Controlling interest
Treasury shares
Total
Balance at Dec. 31, 2023 $ 90,063   $ 247,465,817 $ 1,230,511 $ (134,395,762) $ (11,601,403) $ 634,036 $ (4,066,610) $ 113,458,341
Balance (in Shares) at Dec. 31, 2023 90,063,396 14,101,689              
Balance (in Shares) at Dec. 31, 2023               (144,206)  
Net income (loss)   9,836,450 (263,976) 9,572,474
Share-based compensation for employee and director stock awards   116,582 116,582
Foreign currency translation adjustment   (1,895,801) (10,247) (1,906,048)
Balance at Mar. 31, 2024 $ 90,063   247,582,399 1,230,511 (124,559,312) (13,497,204) 359,813 $ (4,066,610) 121,241,349
Balance (in Shares) at Mar. 31, 2024 90,063,396 14,101,689              
Balance (in Shares) at Mar. 31, 2024               (144,206)  
Balance at Dec. 31, 2024 $ 90,083   247,842,445 1,230,511 (122,605,730) (14,919,345) (1,605,878) $ (4,066,610) $ 120,067,165
Balance (in Shares) at Dec. 31, 2024 90,083,396 14,101,689             89,939,190
Balance (in Shares) at Dec. 31, 2024               (144,206)  
Net income (loss)   (1,579,234) (471,748)   $ (2,050,982)
Exercise of stock options      
Exercise of stock options (in Shares) 472              
Share-based compensation for employee and director stock awards   27,066 $ 27,066
Appropriation to statutory reserves   1,812,091 (1,812,091)
Foreign currency translation adjustment   670,911 28,933   699,844
Balance at Mar. 31, 2025 $ 90,083   $ 247,869,511 $ 3,042,602 $ (125,997,055) $ (14,248,434) $ (2,048,693) $ (4,066,610) $ 118,743,093
Balance (in Shares) at Mar. 31, 2025 90,083,868 14,101,689             89,939,662
Balance (in Shares) at Mar. 31, 2025               (144,206)